{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:49:23Z","timestamp":1781743763310,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIHR Senior Research Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41433-018-0330-x","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T13:03:00Z","timestamp":1547643780000},"page":"845-849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Estimate of incidence of ROP requiring treatment in extreme preterms and impact on service\u20147 year review in tertiary unit"],"prefix":"10.1038","volume":"33","author":[{"given":"Shokufeh","family":"Tavassoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"330_CR1","first-page":"46","volume":"21","author":"C Gilbert","year":"2008","unstructured":"Gilbert C, Muhit M. Twenty years of childhood blindness: what have we learnt? Community Eye Health. 2008;21:46\u20137.","journal-title":"Community Eye Health"},{"issue":"Suppl 1","key":"330_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, et al. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1):35\u201349.","journal-title":"Pediatr Res"},{"key":"330_CR3","unstructured":"Guidelines for the screening and treatment of retinopathy of prematurity. 2008 guidelines. \nhttps:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2014\/12\/2008-SCI-021-Guidelines-Retinopathy-of-Prematurity.pdf"},{"key":"330_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity.","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"330_CR5","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group.","year":"2003","unstructured":"Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684\u201394.","journal-title":"Arch Ophthalmol"},{"key":"330_CR6","doi-asserted-by":"publisher","first-page":"e013366","DOI":"10.1136\/bmjopen-2016-013366","volume":"7","author":"GGW Adams","year":"2017","unstructured":"Adams GGW, Bunce C, Xing W, et al. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk. BMJ Open. 2017;7:e013366.","journal-title":"BMJ Open"},{"issue":"6","key":"330_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/bjophthalmol-2014-305561","volume":"99","author":"Sally L Painter","year":"2014","unstructured":"Painter SL, Wilkinson AR, Desai P, et al. Incidence and treatment of retinopathy of prematurity in England between 1990 and 2011: database study. Br J Ophthalmol. 2015;99:807\u201311.","journal-title":"British Journal of Ophthalmology"},{"key":"330_CR8","doi-asserted-by":"publisher","first-page":"F196","DOI":"10.1136\/archdischild-2013-304508","volume":"99","author":"HS Wong","year":"2014","unstructured":"Wong HS, Santhakumaran S, Statnikov Y, et al. Retinopathy of prematurity in English neonatal units: a national population-based analysis using NHS operational data. Arch Dis Child Fetal Neonatal Ed. 2014;99:F196\u2013202.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"330_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/kjo.kjo_45_17","volume":"29","author":"A Goyal","year":"2017","unstructured":"Goyal A, Giridhar A, Gopalakrishnan M. Real-world scenario of retinopathy of prematurity in Kerala. Kerala J Ophthalmol. 2017;29:30\u201334.","journal-title":"Kerala J Ophthalmol"},{"issue":"Suppl 1","key":"330_CR10","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.3346\/jkms.2015.30.S1.S88","volume":"30","author":"JH Hwang","year":"2015","unstructured":"Hwang JH, Lee EH, Ai-Rhan Kim E. Retinopathy of prematurity among very-low-birth-weight infants in Korea: incidence, treatment, and risk factors. J Korean Med Sci. 2015;30(Suppl 1):S88\u201394.","journal-title":"J Korean Med Sci"},{"key":"330_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jcjo.2012.03.027","volume":"47","author":"G Isaza","year":"2012","unstructured":"Isaza G, Arora S. Incidence and severity of retinopathy of prematurity in extremely premature infants. Can J Ophthalmol. 2012;47:296\u2013300.","journal-title":"Can J Ophthalmol"},{"key":"330_CR12","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.12659\/MSM.890688","volume":"20","author":"Q Liu","year":"2014","unstructured":"Liu Q, Yin ZQ, Ke N, Chen XK, Chen L, Fang J, et al. Incidence of Retinopathy of Prematurity in Southwestern China and Analysis of Risk Factors. Med Sci Monit. 2014;20:1442\u201351.","journal-title":"Med Sci Monit"},{"key":"330_CR13","first-page":"F1","volume":"0","author":"S Santhakumaran","year":"2017","unstructured":"Santhakumaran S, Statnikov Y, Gray D, Battersby C, Ashby D, Modi N. Survival of very preterm infants admitted to neonatal care in England 2008-14: time trends and regional variation. Arch Dis Child Fetal Neonatal Ed. 2017;0:F1\u20138.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"330_CR14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/archophthalmol.2009.244","volume":"127","author":"D Austeng","year":"2009","unstructured":"Austeng D, Kallen KB, Ewald UW, et al. Incidence of retinopathy of prematurity in infants born before 27 weeks\u2019 gestation in Sweden. Arch Ophthalmol. 2009;127:1315\u20139.","journal-title":"Arch Ophthalmol"},{"key":"330_CR15","doi-asserted-by":"publisher","first-page":"F240","DOI":"10.1136\/adc.2004.057570","volume":"90","author":"L Haines","year":"2005","unstructured":"Haines L, Fielder AR, Baker H, et al. UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome. Arch Dis Child Fetal Neonatal Ed. 2005;90:F240\u20134.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"330_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, et al. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603\u201315.","journal-title":"N Engl J Med"},{"key":"330_CR17","doi-asserted-by":"crossref","unstructured":"Fleck BW, Williams C, Juszczak E, Cocker K, Stenson BJ, Darlow BA, et al. An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials. Eye 2017; 1\u20137.","DOI":"10.1038\/eye.2017.150"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0330-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:06:18Z","timestamp":1684616778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-018-0330-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1038\/s41433-018-0330-x","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"CW is supported by an NIHR Senior Research Fellowship.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}}]}}